CV Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CV Therapeutics's estimated annual revenue is currently $89.9M per year.(i)
  • CV Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • CV Therapeutics has 580 Employees.(i)
  • CV Therapeutics grew their employee count by -16% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is CV Therapeutics?

CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine. In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.

keywords:N/A

N/A

Total Funding

580

Number of Employees

$89.9M

Revenue (est)

-16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$107.7M585-18%$747.4M
#2
$104M594N/AN/A
#3
$300M59913%$263.3M
#4
$110M607-45%N/A
#5
$57M62544%$434M